|
|
|
Volumn 28, Issue SUPPL. 64, 2001, Pages 39-41
|
|
Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation
|
|
Author keywords
Autoimmune diseases; Conditioning regimens; Hematopoietic stem cell transplantation; Rheumatoid arthritis
|
|
Indexed keywords
ALEMTUZUMAB;
BUSULFAN;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
FLUDARABINE;
MELPHALAN;
RITUXIMAB;
ANTINEOPLASTIC AGENT;
BEAM PROTOCOL;
DRUG DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
PODOPHYLLOTOXIN;
VIDARABINE;
ALOPECIA;
AUTOIMMUNE DISEASE;
AUTOTRANSPLANTATION;
CARDIOTOXICITY;
CONFERENCE PAPER;
DRUG INDUCED DISEASE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
PATIENT SELECTION;
PERIPHERAL BLOOD STEM CELL;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SEIZURE;
STEM CELL TRANSPLANTATION;
WHOLE BODY RADIATION;
ADJUVANT THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
METHODOLOGY;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARTHRITIS, RHEUMATOID;
BUSULFAN;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MELPHALAN;
PODOPHYLLOTOXIN;
RADIOTHERAPY, ADJUVANT;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
VIDARABINE;
|
|
EID: 0034796814
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (16)
|
